Article
Comprehensive genomic profiling and tumor mutational burden in parathyroid carcinoma: a nationwide real-world study from Japan.
Endocrine - 15 Jul 2026
Takano Yuko, Kikumori Toyone, Takeuchi Dai, Ichikawa Takahiro, Ando Yuichi
Abstract excerpt
PURPOSE: Parathyroid carcinoma (PC) is an extremely rare endocrine malignancy with limited treatment options for unresectable or recurrent cases. With the increasing use of comprehensive genomic profiling (CGP), treatment based on genomic findings is becoming more common. However, the frequency and clinical significance of elevated tumor mutational burden (TMB) in PC remain unclear because previous studies have...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
